PROQR THERAPEUTICS EO-04 (0PQ) — Working Capital to Net Assets Ratio
PROQR THERAPEUTICS EO-04 (0PQ) has a Working Capital to Net Assets ratio of 137.1% as of December 2025. Working capital of €67.69 Million (current assets of €100.13 Million minus current liabilities of €32.44 Million) is measured against net assets of €49.37 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 0PQ days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PROQR THERAPEUTICS EO-04 Working Capital to Net Assets (2021–2025)
This chart shows how PROQR THERAPEUTICS EO-04's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 137.1%, reflecting working capital of €67.69 Million against net assets of €49.37 Million EUR. For the complete balance sheet picture, see 0PQ asset base.
Annual Working Capital to Net Assets for PROQR THERAPEUTICS EO-04 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for PROQR THERAPEUTICS EO-04 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PROQR THERAPEUTICS EO-04 (0PQ) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 137.1% | €67.69 Million | €49.37 Million | €100.13 Million | €32.44 Million | ▲ +7.3 pp |
| 2024 | 129.8% | €114.94 Million | €88.56 Million | €153.84 Million | €38.90 Million | ▼ -79.9 pp |
| 2023 | 209.7% | €86.78 Million | €41.39 Million | €120.99 Million | €34.20 Million | ▲ +9.5 pp |
| 2022 | 200.2% | €133.47 Million | €66.68 Million | €154.46 Million | €20.99 Million | ▲ +55.4 pp |
| 2021 | 144.7% | €163.89 Million | €113.23 Million | €191.48 Million | €27.60 Million | — |